$105.00
-1.60-1.5%
At close: Aug 26, 5:00 PM EST
$105.00
-1.60-1.5%
Pre-Market: 8:21 AM EST
Haemonetics Corp
HAENYSE
Haemonetics Earnings & Forecasts
Haemonetics (HAE) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Haemonetics Guidance
Haemonetics (HAE) last issued guidance on August 6, 2026 for fiscal year 2027. The company guided revenue in the range of $1.4B - $1.44B for the period.
Compared to prior guidance, Haemonetics maintained its revenue forecast from a prior range of $1.41B - $1.43B.
Haemonetics has issued 17 guidance updates between November 7, 2022 and August 6, 2026. During this period, the company raised its outlook 9 times and lowered it 1 time, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q1 '27 | Q4 '26 | Q3 '26 | Q2 '26 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $1.09 | $1.27 | $1.26 | $1.11 |
| Actual | $1.14 | $1.29 | $1.31 | $1.27 |
| Surprise | +4.59% | +1.57% | +3.97% | +14.4% |
| Revenue | ||||
| Estimate | $329.2M | $337.1M | $333.3M | $311.3M |
| Actual | $339.4M | $346.4M | $339.0M | $327.3M |
| Surprise | +3.10% | +2.74% | +1.70% | +5.14% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q2 '27E | Q3 '27E | Q4 '27E | Q1 '28E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $1.29 | $1.36 | $1.48 | $1.26 |
| Revenue | ||||
| Consensus | $345.4M | $356.8M | — | — |
